您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > FSL-1 TFA
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
FSL-1 TFA
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
包装:100 μg
市场价:1600元

产品介绍
FSL-1 TFA 是细菌衍生的一种 Toll 样受体 2/6 (TLR2/6) 激动剂,可增强对 HSV-2 感染的抵抗力。FSL-1 TFA 通过TLR2NF-κB/AP-1信号通路诱导MMP-9产生。
生物活性

FSL-1 TFA, a bacterial-derivedtoll-like receptor2/6 (TLR2/6) agonist, enhances resistance to experimental HSV-2infection[1]. FSL-1 TFA inducesMMP-9production throughTLR2andNF-κB/AP-1signaling pathways in monocytic THP-1 cells[2].

IC50& Target[1][2]

TLR2

 

TLR6

 

MMP-9

 

体外研究
(In Vitro)

FSL-1 significantly reduces HSV-2 replication in human vaginal epithelial cells (EC)[1].
FSL-1 induces significant resistance to experimental genital HSV-2 infection through elaboration of a specific cytokine response profile[1].
FSL-1 (50 ng/mL, 24 hours) induces MMP-9 expression at both mRNA and protein levels in human monocytic THP-1 cells[2].
FSL-1 activates the MAP kinase/NF-κB signaling pathway[2].

Cell Viability Assay[1]

Cell Line:V11I, V12I or V19I immortalized human vaginal EC
Concentration:6 μg or 0.1 μg
Incubation Time:Added at 24, 6 or just prior to HSV-2 inoculation (104pfu/well)
Result:The 6 μg does produced significant reductions when delivered at 24 or 6 h prior to HSV-2 inoculation. The 0.1 μg dose produced reduced HSV-2 replication at 24 or 6 h prior to viral challenge.
体内研究
(In Vivo)

FSL-1 application significantly protectes against genital HSV-2 challenge in mice[1].

Animal Model:Female Swiss-Webster mice (weighing 20-25 g)[1]
Dosage:2 or 6 μg
Administration:Delivered vaginally using a positive displacement pipet, prior to or following viral challenge as specified for each experiment.
Result:The 2 μg does delivered 6 h prior to HSV-2 challenge increased the ID50 (260 pfu) and LD50 (660 pfu) by 10-fold compared to DPBS vehicle control.
The single 6 μg dose produced significantly improved outcomes compared to DPBS vehicle application.
分子量

1780.18

性状

Solid

Formula

C82H141F3N14O20S

Sequence Shortening

S-(2, 3-Bispalmitoyloxypropyl)-CGDPKHPKSF

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

-80°C

溶解性数据
In Vitro: 

H2O : 50 mg/mL(28.09 mM;Need ultrasonic)

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM0.5617 mL2.8087 mL5.6174 mL
5 mM0.1123 mL0.5617 mL1.1235 mL
10 mM0.0562 mL0.2809 mL0.5617 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months。-80℃ 储存时,请在 6 个月内使用。